The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
$39 million
We are sitting at 52 week lows so everyone who bought in the last year is at a loss , don’t think it’s only you, try not to worry it’s only money at the end of the day
Both directors now sitting on a £225k loss from last placing, I’m sure they are both aware of this and will be looking to see some upwards movement sooner rather than later..
Partnership?
Xenor there are at least 3 catalysts that have driven this from under £1 that I can think of off the top of my head:
Micheal J Fox Parkinson’s partnership.
Collaboration with Merck (German) and Pfizer .
Nasdaq listing to complete Q1 2021.
Could be a buy or sell, shorts closing or spread bets , after hours buy/sells are never straight forward ..
Raised £7.7 million on 10th July 2020 @35p one month later share price was circa 70p..
Someone once said to me being invested in early stage non revenue making pharma and not expecting placing/fund raising is like entering into a boxing match and not expecting to get punched..
Bought in today for LTH at 72.42 , mainly based on vaccine and boosters jabs just my thoughts. GLA
When this moves it moves fast , trust me you don’t want to be out when Nasdaq news drops, a lot of trading platforms are ‘closing positions only’ already, buying it won’t be easy...
Mansion02 maybe you should tell MERCK they’ve invested in a dud?